Lapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Study


Kaplan M. A. , Isikdogan A., Koca D., Kucukoner M., Gumusay O., Yildiz R., ...More

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 30
  • City: Illinois
  • Country: United States Of America